1. OC-0318: Neurotoxicity of early prophylactic cranial radiation and hippocampal avoidance in SCLC (SAKK 15/12). (November 2020) Authors: Vees, H.; Caparrotti, F.; Eboulet, E.I.; Xyrafas, A.; Fuhrer, A.; Meier, U.; Mark, M.; Elicin, O.; Aebersold, D.M.; Zwahlen, D.R.; Finazzi, T.; Said Allal, A.; Putora, P.M.; Martucci, F.; Biaggi Rudolf, C.; Ribi, K. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer—The ETOP NICOLAS trial. (July 2019) Authors: Peters, S.; Felip, E.; Dafni, U.; Belka, C.; Guckenberger, M.; Irigoyen, A.; Nadal, E.; Becker, A.; Vees, H.; Pless, M.; Martinez-Marti, A.; Tufman, A.; Lambrecht, M.; Andratschke, N.; Piguet, A.C.; Kassapian, M.; Roschitzki-Voser, H.; Rabaglio-Poretti, M.; Stahel, R.A.; Vansteenkiste, J. Journal: Lung cancer Issue: Volume 133(2019) Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗